07 April 1994 00:00 [Source: ICB]
Australian company Cortecs, whose operations are based in the UK, has listed its shares on the London stock exchange, expanding its equity base by £15m ($22.5m). The placing is raising new cash of £10.6m for the company, which specialises in the R&D of drug delivery systems, and also manufactures otc and diagnostic products. The proceeds are expected to meet Cortecs' funding requirements for the next two years.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
Sample issue >>
My Account/Renew >>
Register for online access >>
|ICIS Top 100 Chemical Companies|
|Download the listing here >>|